ArticleJournal of comparative effectiveness research2024

Evaluating the robustness of an AI pathfinder application on eligibility criteria in multiple myeloma trials using real-world data and historical trials.

Rana Jreich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.